Skip to main content

Rocephin News

Rise in Drug-Resistant Gonorrhea in China May Pose Global Threat

THURSDAY, March 28, 2024 – Cases of a strain of highly antibiotic-resistant gonorrhea that first emerged in China in 2016 have tripled there in just five years, according to research published in...

FDA Medwatch Alert: Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g...

FDA Medwatch Alert: Rocephin (ceftriaxone sodium) for Injection

[Posted 07/05/2007] Roche and FDA informed healthcare professionals of revisions to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and DOSAGE AND ADMINISTRATION sections of the...

FDA Medwatch Alert: Ceftriaxone (marketed as Rocephin and generics)

[Posted 04/14/2009] FDA notified healthcare professionals of an update to a previous alert that addresses the interaction of ceftriaxone with calcium-containing products, based on previously reported...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection, Otitis Media, Pneumonia, Prostatitis, Skin and Structure Infection, Skin Infection, Bronchitis, Eye Conditions, Gastroenteritis, Kidney Infections, Lyme Disease, Urinary Tract Infection

Rocephin patient information at Drugs.com